Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Osteosarcoma × Doxorubicin × Clear all

Phase

Status

Sponsor Class

OTHER 16 NIH 4 NETWORK 4 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Lymphoma, T-Cell, Peripheral 2 Sarcoma 1 Rhabdomyosarcoma 1 Osteosarcoma 1 Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement 1 Carcinoma, Hepatocellular 1

Interventions

spartalizumab 1 apatinib 1 Zoledronic Acid 1 Nivolumab 1 Ipilimumab 1 Ifosfamide 1 Doxorubicin 1 Ashwagandha 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00691236 2011-06-23

ZOL

Tata Memorial Hospital

Phase 2/3 Unknown

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡